IMPEDX DIAGNOSTICS

ImpeDx Diagnostics is a start-up medical device company founded in 2013, that has secured exclusive rights to develop and market a novel system for rapid detecting bacteria in blood culture specimens for use in clinical laboratories. Their mission is to reduce the mortality rate of septic patients by providing rapid diagnostic products, which will allow clinicians to administer target therapeutic treatments sooner. Their technology compresses blood culture results from days to hours. Not only will rapid identification improve the mortality rate, but it will also have a major impact on healthcare savings.